Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma
ChiCTR-IPR-17011696Phase 4Not yet recruiting
- Sponsor
- Yulin First People's Hospital
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of thalidomide in stomatitis (2 arms), sponsored by Yulin First People's Hospital. Primary endpoints: Visual analogue scale for oral pain (VAS) and RTOG grade of oral mucositis. Planned start Apr 2017; status: not yet recruiting.
02
Drugs
thalidomide
03
Conditions
stomatitis
Beyond the preview
Go deeper on ChiCTR-IPR-17011696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011696.